ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nextech Wins Two Best in KLAS Awards, Earning Top Honors in Dermatology and Ophthalmology

TAMPA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nextech, the leader in healthcare technology and practice management solutions for specialty providers, announced today its recognition in the highly competitive 2025 Best in KLAS® Software and Services Report. Both Nextech’s dermatology electronic health record (EHR) and ophthalmology EHR were awarded, earning top honors in the Ambulatory Specialty EHR and Ambulatory Ophthalmology Solutions categories.

KLAS, a trusted authority in health technology research, evaluates leading healthcare software providers based on real-world performance and client experiences. The annual Best in KLAS report highlights innovative industry solutions that enhance care delivery and patient experience. These rankings are built on extensive, independent interviews with thousands of providers to ensure an unbiased assessment of each company’s impact, reliability, and customer commitment.

"Congratulations to the 2025 winners of the Best in KLAS awards! In the ever-evolving healthcare landscape, achieving excellence is no small feat,” said Adam Gale, CEO of KLAS. “Winning a ‘Best in KLAS’ award signifies a commitment to delivering outstanding value and innovation to healthcare providers and patients. It is a testament to their hard work, dedication, and passion — all needed to drive our industry forward. It is my hope that these awards inspire the winners and other companies to reach new heights."

Winning a second consecutive Best in KLAS award validates Nextech’s industry leadership and long-standing success as a driver for more meaningful provider-patient interactions and improved health outcomes. The company’s continued commitment to innovation and customer success is focused on creating greater value for the customers and specialty markets they serve.

"Receiving two Best in KLAS awards is a testament to Nextech’s commitment to delivering innovative, specialty-specific technology that simplifies workflows and enhances patient care,” said Rusty Frantz, CEO of Nextech. “This recognition reflects our dedication to empowering healthcare providers with technology that drives efficiency, improves outcomes, and supports meaningful patient interactions. We are proud to be a trusted partner for specialty practices, helping them thrive and make a lasting impact on the communities they serve."

In addition to this recognition by KLAS, Nextech’s CEO, Rusty Frantz, was recently honored as one of the top 50 healthcare CEOs by Healthcare Technology Report. These honors continue to affirm Nextech's position as a trusted advisor and leader in purpose-built technology platforms for specialty healthcare and wellness providers.

To learn more about Nextech and its award-winning technology visit, https://www.nextech.com.

About Nextech
Nextech is the complete healthcare technology solution for specialty providers. Since 1997, Nextech has been focused on delivering innovative solutions and services that drive efficiency, fuel growth, and enhance the patient care experience. Nextech services more than 16,000 physicians and over 60,000 office staff members in the clinical specialties of dermatology, med spa, ophthalmology, orthopedics, and plastic surgery.

Jenna Paulus
Director of Corporate Communications
j.paulus@nextech.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.